Cheng and Guo have reported INCB28060, produced by Selleck Chemicals LLC, type I/II, to be a potent and selective inhibitor of MET kinase and to show strong anti-tumor activity in MET-dependent mouse tumor models [74]. Here, MET is linked to neoplasm.